Pivotal Therapeutics (PVTTF) 0.0010 $PVTTF IIROC Trading

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pivotal Therapeutics (PVTTF) 0.0010 $PVTTF

IIROC Trading Halt - PVO
CNW Group - Thu May 05, 7:25AM CDT
The following issues have been halted by IIROC:

Pivotal Therapeutics Announces Issuance of US Patent 9,248,138 for the Stabilization of Vulnerable Plaque Utilizing a Combination of Statin and Omega 3 Fatty Acids
TheNewswire.ca - Tue Feb 02, 4:36PM CST
(via Thenewswire.ca)

Pivotal Therapeutics Announces Payment of Interest on Outstanding Convertible Notes
TheNewswire.ca - Mon Jan 04, 8:28PM CST
(via Thenewswire.ca)

Pivotal Therapeutics Announces Third Quarter Financial Results and Executes Distribution Agreement
TheNewswire.ca - Mon Nov 30, 11:43AM CST
(via Thenewswire.ca)

BeneFishial(TM) Pet Formulation Approved For Sale - The First in Pivotal's Animal Health and Nutrition Line
TheNewswire.ca - Wed Nov 25, 4:46PM CST
(via Thenewswire.ca)

Pivotal Announces Publication Evaluating 171 Over-the-Counter (OTC) Omega-3 Nutritional Supplements - 50% of the OTC Products Failed at Least one of the Oxidative Safety Limits
TheNewswire.ca - Fri Nov 06, 2:12PM CST
(via Thenewswire.ca)

Pivotal Receives Notice of Allowance for U.S. Application 14/594,095 for the Stabilization of Vulnerable Plaque Utilizing a Combination of Statin and PVT-100
TheNewswire.ca - Thu Oct 08, 2:36PM CDT
(via Thenewswire.ca)

Pivotal Therapeutics Announces Issuance of U.S. Patent 9,119,826 for a Kit that Includes Vascazen(tm) and an Omega-3 Fatty Acid Diagnostic Asssay for the Dietary Management of Cardiovascular Patients Deficient in Omega-3
TheNewswire.ca - Tue Sep 22, 6:00AM CDT
(via Thenewswire.ca)

Pivotal Therapeutics Announces Second Quarter Financial Results
TheNewswire.ca - Fri Aug 28, 8:52PM CDT
(via Thenewswire.ca)

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100
CNW Group - Thu Jun 04, 1:25PM CDT
Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today the enrollment of the first patient in Pivotal's POMEGA Phase IIa clinical trial with PVT-100.

Pivotal Therapeutics Announces First Quarter Financial Results
PR Newswire - Mon Jun 01, 8:19PM CDT
Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended March 31, 2015. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated.

Pivotal Therapeutics Inc. is to be Featured on CEO Clips on CBC's The Documentary Channel
PR Newswire - Mon May 11, 2:17PM CDT
Pivotal Therapeutics Inc. (CSE VO; OTCQX VTTF), ("Pivotal" or the "Company" , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today the company and Mrs. Rachelle MacSweeney, Co-Founder, President and COO will be featured on CEO Clips on CBC's The Documentary Channel. CEO Clips, a series which profiles the most innovative publicly traded companies in North America, will feature Pivotal on The Documentary Channel beginning May 11, 2015, Monday through Friday, throughout the day and evenings. It can also be viewed online via this link: http://www.b-tv.com/pivotal-therapeutics-ceo-clip/.

Pivotal Therapeutics Announces 2014 Financial Results
PR Newswire - Thu Apr 30, 8:20PM CDT
Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the fiscal year ended December 31, 2014. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated.

Pivotal receives Health Canada approval to expand the indication of OMAZEN® to include products with claims to maintain and support cardiovascular health and normal triglyceride levels
PR Newswire - Mon Apr 27, 11:48AM CDT
Pivotal Therapeutics Inc. (OTCQX VTTF; CSE VO), ("Pivotal" or the "Company" , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that it received Health Canada approval to expand the indication of OMAZEN®'s product line specifically for cardiovascular health. The Natural and Non-Prescription Health Products Directorate of Health Canada (NNHPD) issued Natural Product Number (NPN) NPN 80060196 with the claim that helps to maintain and support cardiovascular health and NPN 80060197 with the claim helps to support and maintain normal serum/blood triglycerides/triacylglycerol levels. These new products contain the same unique formulation and high purity as OMAZEN® and will also be positioned for the professional market such as Wellness Clinics, Cardiac Rehabilitation Clinics, Sports Medicine Clinics and Private Executive Healthcare Clinics.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OCI Faces Legal Hurdles Amid Merger Efforts

Updated Category News Views 2

OCI Global Gets Twist Thrown Into Merger Plans OCI Global's strategic maneuver with Orascom Construction is hitting a snag. Value8 N.V. has thrown a wrench in the works by filing a petition with Amsterdam's Enterprise Chamber. Looks like this little courtroom tango could pump the brakes on the proposed merger deal. Now, if you're holding shares, it's time to pay attention...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 5

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
Eosera Defies Odds with Texas-Made Ear Care Dominance

Updated Category News Views 3

Who would've thought an ear care outfit outta Fort Worth could snag a spot on the Inc. 5000 list for six years running? That's right, eosera® is hanging tough, even while the industry's been in a tailspin and tariffs have been squeezing everyone’s margins. Pushing Through Tough Terrain The ear care sector isn't exactly the first place investors look for a splash,...

Continue Reading
Herzog Joins Greenberg Traurig: A Litigation Powerhouse

Updated Category News Views 5

Greenberg Traurig Welcomes David M. Herzog to the Team Ah, the rat race of litigation just got a bit fiercer with Greenberg Traurig's latest acquisition: David M. Herzog. This isn’t just another lawyer joining the ranks; Herzog's a dynamo, coming in hot from the U.S. Attorney's Office, right onto the battlefield of corporate litigation. Why Herzog's Move Matters...

Continue Reading
Beyoncé Drops Remastered 'B'DAY'; Celebrates Legacy

Updated Category News Views 1

Every so often, an artist comes around who's not just making music but shifting the very landscape of their genre. Beyoncé isn't just marking her birthday today; she's reminding the world of a career-defining moment with the release of her remastered deluxe version of 'B'DAY'. This isn't just a stroll down memory lane; it's a full-blown revival of an era that reshaped...

Continue Reading
Project 777 Bolsters Leadership with AI and Space Experts

Updated Category News Views 3

Fortifying Project 777 with Tech Titans You'd think bolstering a team THIS stacked would feel daunting to others in the AI race, but A2035 Ventures is just getting started. Their latest move? Bringing in Sean Perry from Meta's Agentic AI and Preston Dunlap, ex-CTO of the U.S. Space Force. These aren't your garden-variety hires; they signify a deliberate step into the next...

Continue Reading
Narwal Unveils 2026 AI Cleaning Lineup at IFA Berlin

Updated Category News Views 2

A Fresh Sweep with AI: Narwal's 2026 Lineup Hot off the press from Berlin's IFA 2026, Narwal is making some serious waves with its latest household cleaning gadgets. This isn't just another batch of robot helpers; Narwal's aiming to redefine what AI-driven cleaning can do for your home. FlowWash: Not Just Another Cleaning Gimmick Narwal's been at this game for over a...

Continue Reading
Mohegan Sun's Star-Studded 30th Year Bash: Details Inside

Updated Category News Views 5

Mohegan Sun Hits the Big 3-0 with a Bang When a casino decides to throw a party, you already know they spare no expense. Mohegan Sun's hitting the big thirty this October, and they've got a lineup that screams celebration. This isn’t just about a glossy red carpet or celebrity sightings, folks. It’s about a milestone that reflects years of stellar entertainment,...

Continue Reading
Taiwan's Machine Emerges as Heavy-Tonnage Game Changer

Updated Category News Views 2

Every once in a while, the machinery scene gets rocked by something that genuinely raises eyebrows, and it seems Chuan Lih Fa Machinery Works Co., Ltd. (CLF) has just delivered one of those moments. This isn't just any old injection molding machine—it's Taiwan's very first 5000-ton giant, crafted with robust precision and dispatched straight to a major U.S. logistics...

Continue Reading
Cypress Wood's Resilience in Louisiana's Humidity

Updated Category News Views 1

Timber Talk with Wes McAdams Diving into the nitty-gritty of building materials isn't everyone's cup of tea, but when you live in a place like Baton Rouge, understanding what stands up to the swampy summer heat is plain survival. The main focus? Cypress wood. Now, Wes McAdams from Cajun Cypress throws his hat into the ring, shedding some light on why cypress might just be...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Impact of DS-01® on Gut and Immune Health

Updated Category News Views 238

Introduction to DS-01® and its Innovative Formulation DS-01® stands out as a pioneering broad-spectrum synbiotic, clinically proven to elevate the levels of two important microbial metabolites: Urolithin A and butyrate. These metabolites are vital to overall health, with extensive implications for gut, metabolic, immune, and cellular well-being. Recent Findings...

Continue Reading
Arbor Realty Trust Investors Urged to Act in Class Action Suit

Updated Category News Views 176

Arbor Realty Trust, Inc. (NYSE: ABR) found itself in hot water back in 2024 as the news of a class-action lawsuit started making waves across trading desks. The firm’s handling of its financial disclosures caught the attention of Kahn Swick & Foti, LLC, leading to serious allegations against the company and several executives. Investors holding over $100,000 in losses...

Continue Reading
DMG Blockchain Solutions Reports December Mining Success

Updated Category News Views 82

DMG Blockchain Solutions Reports Strong Mining Results DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) is thrilled to announce its preliminary mining results for the recent month. With a notable performance in December 2024, DMG mined a total of 32 BTC for the month, contributing to an impressive quarterly output. Impressive December Outcomes...

Continue Reading
Fortune Bay's Strategic Initiative: Environmental Engagement for Goldfields

Updated Category News Views 153

Fortune Bay Leads the Way with Environmental Studies Fortune Bay Corp. (TSXV: FOR, OTCQB: FTBYF) is embarking on an important initiative to advance its 100% owned Goldfields Project, a strategic growth asset crucial for the company's future. This initiative encompasses comprehensive environmental baseline studies and a proactive approach to community engagement, set to...

Continue Reading
Penn Station East Coast Subs Celebrates New MEGA CHEESESTEAK

Updated Category News Views 379

Introducing the MEGA CHEESESTEAK from Penn Station East Coast Subs A Exciting New Menu Item Penn Station East Coast Subs is thrilled to unveil an innovative menu addition that promises to excite food lovers across the country—the MEGA CHEESESTEAK. This creation showcases the exceptional quality and flavor that the franchise is celebrated for, perfectly marrying...

Continue Reading